Roxadustat, a Hypoxia-Inducible Factor 1α Activator, Attenuates Both Long- and Short-Term Alcohol-Induced Alcoholic Liver Disease
Alcoholic liver disease (ALD) is a worldwide healthcare problem featured by inflammation, reactive oxygen species (ROS), and lipid dysregulation. Roxadustat is used for chronic kidney disease anemia treatment. As a specific inhibitor of prolyl hydroxylase, it can maintain high levels of hypoxia-indu...
Saved in:
Main Authors: | Yongyao Gao (Author), Xiaomeng Jiang (Author), Daigang Yang (Author), Wentong Guo (Author), Dandan Wang (Author), Ke Gong (Author), Ying Peng (Author), Hong Jiang (Author), Cunyuan Shi (Author), Yajun Duan (Author), Yuanli Chen (Author), Jihong Han (Author), Xiaoxiao Yang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Intermittent Fasting Inhibits High-Fat Diet-Induced Atherosclerosis by Ameliorating Hypercholesterolemia and Reducing Monocyte Chemoattraction
by: Yuanli Chen, et al.
Published: (2021) -
Roxadustat: Not just for anemia
by: Xiaoyu Zhu, et al.
Published: (2022) -
Roxadustat for Patients with Posttransplant Anemia: A Narrative Review
by: Xiaoxiao Tang, et al.
Published: (2023) -
Procyanidin B2 Reduces Vascular Calcification through Inactivation of ERK1/2-RUNX2 Pathway
by: Yingquan Liang, et al.
Published: (2021) -
Roxadustat (FG-4592) Facilitates Recovery From Renal Damage by Ameliorating Mitochondrial Dysfunction Induced by Folic Acid
by: Xue Li, et al.
Published: (2022)